Rie Onodera Selected Research

Rie Onodera Research Topics

10	Stroke (Strokes) 07/2022 - 06/2011
4	Spinal Cord Injuries (Spinal Cord Injury) 07/2022 - 01/2008
4	Cerebral Infarction 02/2019 - 02/2013
4	Chronic Limb-Threatening Ischemia 02/2010 - 08/2007
3	Ischemic Stroke 07/2022 - 10/2017
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2019 - 10/2017
3	Ischemia 02/2010 - 11/2008
3	Thromboangiitis Obliterans (Buerger's Disease) 02/2010 - 11/2008
2	Disease Progression 01/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 11/2016 - 05/2012
2	Pain (Aches) 11/2009 - 11/2008
2	Ulcer 11/2009 - 11/2008
2	Peripheral Arterial Disease 11/2009 - 11/2008
1	Chronic Brain Injury 07/2022
1	Atrial Fibrillation 07/2022
1	Embolic Stroke 07/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Hyperplasia 10/2019
1	Pathologic Constriction (Stenosis) 10/2019
1	Brain Stem Infarctions (Weber Syndrome) 10/2018
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Neutropenia 11/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2017
1	Immunoglobulin G4-Related Disease 02/2014
1	Adenoma (Adenomas) 02/2014
1	Phlebitis 02/2014
1	Inflammation (Inflammations) 02/2014
1	Fibrosis (Cirrhosis) 02/2014
1	Infarction (Infarctions) 06/2011
1	Sensorineural Hearing Loss 11/2010
1	Connective Tissue Diseases (Connective Tissue Disease) 02/2010
1	Arteriosclerosis Obliterans 02/2010
1	Gangrene 02/2010
1	Chronic Granulomatous Disease 12/2009

3	Therapeutic UsesIBA 01/2021 - 05/2012
2	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2018
2	GelatinIBA 11/2010 - 08/2007
2	HydrogelsIBA 11/2010 - 08/2007
2	Troleandomycin (TAO)FDA Link 02/2010 - 11/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2010 - 11/2009
2	Oxygen (Dioxygen)IBA 11/2009 - 11/2008
2	Pain-FreeIBA 11/2009 - 11/2008
1	Thrombin FDA Link 07/2022
1	apixabanIBA 07/2022
1	Factor Xa (Coagulation Factor Xa)IBA 07/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2022
1	AnticoagulantsIBA 07/2022
1	RivaroxabanIBA 07/2022
1	Dabigatran FDA Link 07/2022
1	NeurturinIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2019
1	AntibodiesIBA 11/2017
1	AntigensIBA 11/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2017
1	Immunoglobulin G (IgG)IBA 02/2014
1	Neuroprotective AgentsIBA 05/2012
1	Insulin-Like PeptidesIBA 11/2010
1	GlucocorticoidsIBA 11/2010
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2007

11	Intravenous Infusions 07/2022 - 02/2013
6	Therapeutics 07/2022 - 11/2008
5	Transplantation 02/2013 - 01/2008
2	Surgical Amputation (Amputations) 02/2010 - 11/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2009 - 11/2008
2	Cell Transplantation 11/2009 - 11/2008
1	Secondary Prevention 07/2022
1	Stents 10/2019
1	Intravenous Administration 06/2011
1	Limb Salvage 02/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2009
1	Intramuscular Injections 11/2008